Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reducing overtreatment.

Blaise F D Bourgeois1

  • 1Harvard Medical School, Children's Hospital, Hunnewell 2, 300 Longwood Avenue, Boston, MA 02115, USA. blaise.bourgeois@tch.harvard.edu

Epilepsy Research
|November 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lennox-Gastaut syndrome: a consensus approach to differential diagnosis.

Epilepsia·2014
Same author

Surgery for intractable epilepsy due to unilateral brain disease: a retrospective study comparing hemispherectomy techniques.

Pediatric neurology·2014
Same author

Safety and retention rate of rufinamide in 300 patients: a single pediatric epilepsy center experience.

Epilepsia·2014
Same author

Initiating antiepileptic drug treatment and characteristics of drugs.

Handbook of clinical neurology·2013
Same author

Efficacy of antiepileptic drugs in adults vs children: does one size fit all?

Neurology·2012
Same author

Somatic activation of AKT3 causes hemispheric developmental brain malformations.

Neuron·2012
Same journal

Access to inpatient video-EEG monitoring for patients with frequent seizure-related emergency visits.

Epilepsy research·2026
Same journal

Effect of the ketogenic diet on absence seizures in rats with genetic absence epilepsy.

Epilepsy research·2026
Same journal

Diagnostic accuracy of artificial intelligence models for seizure outcome prediction after epilepsy surgery: A systematic review and meta-analysis.

Epilepsy research·2026
Same journal

Quality assessment of persian epilepsy mobile applications: A systematic review using uMARS and DISCERN.

Epilepsy research·2026
Same journal

Effectiveness and safety of brivaracetam in patients with focal epilepsy: A systematic review and meta-analysis.

Epilepsy research·2026
Same journal

Small sharp spikes precede the development of epileptiform discharges in temporal lobe epilepsy.

Epilepsy research·2026
See all related articles

Reducing overtreatment in epilepsy can improve outcomes and lower costs, but carries risks like seizure worsening. Careful drug selection, reduction rate, and interaction monitoring are crucial challenges.

Area of Science:

  • Clinical Neurology
  • Pharmacology
  • Epilepsy Management

Background:

  • Epilepsy treatment can lead to overtreatment, which is difficult to reverse.
  • Reducing overtreatment offers benefits such as fewer side effects, better seizure control, simplified regimens, improved compliance, and reduced costs.

Purpose of the Study:

  • To explore the challenges and considerations in reducing antiepileptic drug overtreatment.
  • To highlight the need for evidence-based recommendations for decreasing antiepileptic drug dosages.

Main Methods:

  • Review of potential benefits and risks associated with reducing antiepileptic drug overtreatment.
  • Identification of key challenges in the process: drug selection, reduction rate, and pharmacokinetic interactions.
  • Assessment of the current lack of published data supporting overtreatment reduction strategies.

Related Experiment Videos

Main Results:

  • Risks of reducing overtreatment include seizure exacerbation from withdrawal or loss of protection, and potential drug toxicity from reversed pharmacokinetic interactions.
  • Key challenges involve selecting which drugs to eliminate, determining the appropriate reduction rate, and anticipating significant pharmacokinetic interactions.
  • There is a notable scarcity of data to guide the reduction of overtreatment, especially in pediatric populations and with newer antiepileptic drugs.

Conclusions:

  • Reducing antiepileptic drug overtreatment presents significant challenges requiring careful management.
  • Further research is needed to develop evidence-based guidelines for safe and effective reduction of antiepileptic drug therapy, particularly for vulnerable groups.